The efficacy and safety of neoadjuvant buparlisib for breast cancer
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000017614
Abstract: Abstract Introduction: The efficacy of neoadjuvant buparlisib for breast cancer remains controversial. We conduct a systematic review and meta-analysis to explore the influence of neoadjuvant buparlisib versus placebo for breast cancer. Methods: We search PubMed,… read more here.
Keywords: breast cancer; efficacy; neoadjuvant buparlisib; buparlisib ... See more keywords